HbA2 Leuven and Its Impact on HbA1c Results

N/ACompletedNCT01909648

Universitaire Ziekenhuizen KU Leuven10 enrolled

Overview

The study is designed to demonstrate HbA2 Leuven mutation and to asssess its impact on routine HbA1c measurements.

HbA2 Leuven mutation will be investigated using molecular diagnostic techniques. Interference on HbA1c measurements will be assessed in HbA2 Leuven carriers using different methodologies.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Family Study HbA2 Leuven Mutation.

Interventions

Blood withdrawalOTHER

Blood withdrawalGENETIC

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Family history of HbA2 Leuven mutation. Exclusion Criteria: * Any condition inhibiting simple blood withdrawal.

Locations (1)

UZLeuven

Leuven, Belgium

Outcomes

Primary Outcomes

Demonstration of presence/absence of HbA2 Leuven mutation

Time frame: 1 year

Secondary Outcomes

Demonstration of impact of HbA2 Leuven mutation on routine HbA1c measurements

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.